Vanguard Group Inc Alkermes Plc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,496,185 shares of ALKS stock, worth $653 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,496,185

Previous 18,971,637 2.51%

Holding current value

$653 Million

Previous $531 Million 0.18%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$25.7 - $31.46 $12.2 Million - $15 Million	-475,452 Reduced 2.51%	18,496,185 $532 Million
Q3 2024 Nov 13, 2024	SELL	$23.01 - $28.55 $23.7 Million - $29.4 Million	-1,028,235 Reduced 5.14%	18,971,637 $531 Million
Q2 2024 Aug 13, 2024	SELL	$23.21 - $27.24 $3.74 Million - $4.39 Million	-161,308 Reduced 0.8%	19,999,872 $482 Million
Q1 2024 May 10, 2024	SELL	$26.4 - $32.56 $21 Million - $25.9 Million	-794,274 Reduced 3.79%	20,161,180 $546 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $53.5 Million - $65.6 Million	2,288,185 Added 12.26%	20,955,454 $581 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $1.98 Million - $2.33 Million	72,797 Added 0.39%	18,667,269 $523 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $387,407 - $459,722	-13,670 Reduced 0.07%	18,594,472 $582 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $1.75 Million - $2 Million	69,064 Added 0.37%	18,608,142 $525 Million
Q4 2022 Feb 10, 2023	BUY	$21.94 - $26.24 $9.46 Million - $11.3 Million	431,176 Added 2.38%	18,539,078 $484 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $18.2 Million - $26.4 Million	828,769 Added 4.8%	18,107,902 $404 Million
Q2 2022 Aug 12, 2022	BUY	$26.4 - $30.54 $12.8 Million - $14.8 Million	486,023 Added 2.89%	17,279,133 $515 Million
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $2.27 Million - $2.76 Million	-98,600 Reduced 0.58%	16,793,110 $442 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $1.14 Million - $1.7 Million	52,885 Added 0.31%	16,891,710 $393 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $5.57 Million - $7.66 Million	238,336 Added 1.44%	16,838,825 $519 Million
Q2 2021 Aug 13, 2021	BUY	$18.78 - $25.15 $312 Million - $418 Million	16,600,489 New	16,600,489 $407 Million

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.8B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Alkermes Plc. Transaction History